.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Moodys
Baxter
Novartis
McKesson
Colorcon
Farmers Insurance
Dow
QuintilesIMS
Argus Health

Generated: June 26, 2017

DrugPatentWatch Database Preview

RILUZOLE Drug Profile

« Back to Dashboard

Which patents cover Riluzole, and when can generic versions of Riluzole launch?

Riluzole is a drug marketed by Apotex Corp, Sun Pharm Inds Ltd, Mylan Pharms Inc, Alkem Labs Ltd, Impax Labs, and Glenmark Pharms Ltd. and is included in six NDAs.

The generic ingredient in RILUZOLE is riluzole. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the riluzole profile page.

Summary for Tradename: RILUZOLE

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list7
Bulk Api Vendors: see list100
Clinical Trials: see list92
Patent Applications: see list3,101
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RILUZOLE at DailyMed

Pharmacology for Tradename: RILUZOLE

Ingredient-typeBenzothiazoles
Drug ClassBenzothiazole
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Corp
RILUZOLE
riluzole
TABLET;ORAL091300-001Jun 18, 2013ABRXNoNo► Subscribe► Subscribe
Alkem Labs Ltd
RILUZOLE
riluzole
TABLET;ORAL204048-001Mar 30, 2016ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
RILUZOLE
riluzole
TABLET;ORAL091417-001Jun 18, 2013ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
RILUZOLE
riluzole
TABLET;ORAL203042-001Jul 1, 2013ABRXNoNo► Subscribe► Subscribe
Glenmark Pharms Ltd
RILUZOLE
riluzole
TABLET;ORAL091394-001Jun 18, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Cerilliant
Harvard Business School
Dow
Accenture
US Department of Justice
Citi
Baxter
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot